Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chen-Yen Lin

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
Value of PASI90 Versus Merit-Based Incentive Payment System Efficacy MeasuresJason E Hawkes, Paulo Reis, Chen-Yen Lin, et al.
Biomedical Optics Express|November 22, 2016
<i>In vivo</i> volumetric fluorescence sectioning microscopy with mechanical-scan-free hybrid illumination imagingChen-Yen Lin, Wei-Hsin Lin, Ju-Hsuan Chien, et al.
Journal of Drugs in Dermatology : JDD|August 27, 2020
Nail Psoriasis Does Not Affect Skin Response to Ixekizumab in Patients With Moderate-To-Severe PsoriasisPhoebe Rich, Orin Goldblum, Damon Disch, et al.
Rheumatology (Oxford, England)|January 22, 2021
Improvement from ixekizumab treatment in patients with psoriatic arthritis who have had an inadequate response to one or two TNF inhibitorsBruce Kirkham, Carlos Sesin, Amanda M Gellett, et al.
Journal of Biophotonics|October 30, 2020
Telecentric design for digital-scanning-based HiLo optical sectioning endomicroscopy with an electrically tunable lensHaw Hsiao, Chen-Yen Lin, Sunil Vyas, et al.
Optics Letters|January 15, 2016
Talbot multi-focal holographic fluorescence endoscopy for optically sectioned imagingChen Yen Lin, Wei-Tang Lin, Hsi-Hsun Chen, et al.
The Journal of Dermatological Treatment|November 8, 2019
Ixekizumab treatment patterns and healthcare utilization and costs for patients with psoriasisMwangi J Murage, Adrienne M Gilligan, Oth Tran, et al.
BMC Dermatology|June 30, 2018
Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilizationApril W Armstrong, Shonda A Foster, Brian S Comer, et al.
RMD Open|January 21, 2020
Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritisDafna Gladman, Peter Nash, Hitoshi Goto, et al.
Acta Dermato-Venereologica|September 21, 2017
Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term ExtensionAlexandra B Kimball, Thomas Luger, Alice Gottlieb, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
Value of PASI90 Versus Merit-Based Incentive Payment System Efficacy MeasuresJason E Hawkes, Paulo Reis, Chen-Yen Lin, et al.
Biomedical Optics Express|November 22, 2016
<i>In vivo</i> volumetric fluorescence sectioning microscopy with mechanical-scan-free hybrid illumination imagingChen-Yen Lin, Wei-Hsin Lin, Ju-Hsuan Chien, et al.
Journal of Drugs in Dermatology : JDD|August 27, 2020
Nail Psoriasis Does Not Affect Skin Response to Ixekizumab in Patients With Moderate-To-Severe PsoriasisPhoebe Rich, Orin Goldblum, Damon Disch, et al.
Rheumatology (Oxford, England)|January 22, 2021
Improvement from ixekizumab treatment in patients with psoriatic arthritis who have had an inadequate response to one or two TNF inhibitorsBruce Kirkham, Carlos Sesin, Amanda M Gellett, et al.
Journal of Biophotonics|October 30, 2020
Telecentric design for digital-scanning-based HiLo optical sectioning endomicroscopy with an electrically tunable lensHaw Hsiao, Chen-Yen Lin, Sunil Vyas, et al.
Optics Letters|January 15, 2016
Talbot multi-focal holographic fluorescence endoscopy for optically sectioned imagingChen Yen Lin, Wei-Tang Lin, Hsi-Hsun Chen, et al.
The Journal of Dermatological Treatment|November 8, 2019
Ixekizumab treatment patterns and healthcare utilization and costs for patients with psoriasisMwangi J Murage, Adrienne M Gilligan, Oth Tran, et al.
BMC Dermatology|June 30, 2018
Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilizationApril W Armstrong, Shonda A Foster, Brian S Comer, et al.
RMD Open|January 21, 2020
Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritisDafna Gladman, Peter Nash, Hitoshi Goto, et al.
Acta Dermato-Venereologica|September 21, 2017
Long-term Impact of Ixekizumab on Psoriasis Itch Severity: Results from a Phase III Clinical Trial and Long-term ExtensionAlexandra B Kimball, Thomas Luger, Alice Gottlieb, et al.
Pageof 5